We serve Chemical Name:3-chloropyridin-2-ol CAS:13466-35-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3-chloropyridin-2-ol
CAS.NO:13466-35-8
Synonyms:3-Chloro-2(1H)-pyridinone;2-Hydroxy-3-chloropyridine;3-chloropyridin-2-ol;3-Chloro-1H-pyridin-2-one;3-Chloro-2-pyridone;2-Pyridinol, 3-chloro-;3-Chloro-2-pyridinol;MFCD01646109
Molecular Formula:C5H4ClNO
Molecular Weight:129.544
HS Code:2933399090
Physical and Chemical Properties:
Melting point:180-182°C
Boiling point:273.7±20.0 °C at 760 mmHg
Density:1.4±0.1 g/cm3
Index of Refraction:1.584
PSA:33.12000
Exact Mass:128.998138
LogP:0.16
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 3-Chloro-2(1H)-pyridinone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD01646109 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Chloro-2-pyridinol Use and application,2-Hydroxy-3-chloropyridine technical grade,usp/ep/jp grade.
Related News: With the speeding up of review and approval, the number of approved innovative drugs in China is about to usher in a year of blowout. 3-chloropyridin-2-ol manufacturer It has reserves in the direction of APIs and intermediates for lowering blood lipids, lowering blood sugar and anticoagulation. 3-chloropyridin-2-ol supplier Wuhan officials estimate about 5 million people had left the city for the annual Lunar New Year holiday before authorities canceled all outbound flights, trains and buses in an unprecedented lockdown on January 23. 3-chloropyridin-2-ol vendor Wuhan officials estimate about 5 million people had left the city for the annual Lunar New Year holiday before authorities canceled all outbound flights, trains and buses in an unprecedented lockdown on January 23. 3-chloropyridin-2-ol factory A week before Eli Lilly (LLY.N) disclosed to regulators that the U.S. Justice Department was investigating its New Jersey factory, the drugmaker told employees that its own inquiry, led by an outside law firm, found no evidence of wrongdoing there, according to a company memo reviewed by Reuters.
